Banque Cantonale Vaudoise’s Clearside Biomedical CLSD Stock Holding History

Banque Cantonale Vaudoise’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,667	Closed	-$52K	–	796
2024 Q2	$52K	Hold	2,667	–	–	﹤0.01%	789
2024 Q1	$61K	Hold	2,667	–	–	﹤0.01%	748
2023 Q4	$47K	Hold	2,667	–	–	﹤0.01%	816
2023 Q3	$35K	Hold	2,667	–	–	﹤0.01%	1007
2023 Q2	$45K	Hold	2,667	–	–	﹤0.01%	979
2023 Q1	$42K	Hold	2,667	–	–	﹤0.01%	985
2022 Q4	$45K	Buy	+2,667	New	+$48K	﹤0.01%	969

Other funds holding CLSD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GGH

GCM Grosvenor Holdings Chicago, Illinois $901M AUM 28.6% 1-Year Est. Return

Banque Cantonale Vaudoise's CLSD Position: Q3 2024 in Review

Banque Cantonale Vaudoise sold out of Clearside Biomedical (CLSD) in Q3 2024, closing a stake of 2,667 shares — an estimated $52K sold.

Banque Cantonale Vaudoise first reported a position in CLSD in Q4 2022 and held it in 7 quarters. The position peaked at $61K in Q1 2024. 48 funds tracked by Wall St. Rank hold CLSD as of Q3 2024.

Banque Cantonale Vaudoise reported no remaining Clearside Biomedical position as of Q3 2024 after selling out during the quarter.
Banque Cantonale Vaudoise sold 2,667 Clearside Biomedical shares in Q3 2024, an estimated $52K.
Banque Cantonale Vaudoise first reported a position in Clearside Biomedical in Q4 2022 and held it in 7 quarters.
Banque Cantonale Vaudoise's Clearside Biomedical position peaked at $61K in Q1 2024.
48 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2024, filed 8 Nov 2024.